March 23, 2017 / 8:19 PM / 5 months ago

BRIEF-Aeglea Bio Q4 revenue $1.2 million versus $1.6 million

March 24 (Reuters) - Aeglea Bio Therapeutics Inc

* Aeglea biotherapeutics provides corporate update and reports fourth quarter and full year 2016 financial results

* Q4 revenue $1.2 million versus $1.6 million

* Q4 revenue view $3.4 million -- Thomson Reuters I/B/E/S

* Aeglea bio therapeutics inc- believes that it has sufficient capital resources to fund anticipated operations through q1 of 2019

* Aeglea bio therapeutics inc- net loss totaled $5.5 million and $4.0 million for q4 of 2016 and 2015, respectively Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below